Wen, P., Odia, Y., Mehta, M., Goldlust, S., Tamir, S., Shacham, S., . . . Li, K. (2020). RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR rGBM). Neuro Oncol.
Chicago-tyylinen lähdeviittausWen, Patrick, Yazmin Odia, Minesh Mehta, Samuel Goldlust, Sharon Tamir, Sharon Shacham, Hongwei Wang, Heidi Sheehan, ja Kai Li. "RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR RGBM)." Neuro Oncol 2020.
MLA-viiteWen, Patrick, et al. "RTID-08. A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (ndGBM OR RGBM)." Neuro Oncol 2020.